For the Inventor, By the Inventor

Enter assignee name

Bedminster, NJ, United States of America

Intra-Cellular Therapies, Inc.

USPTO Granted Patents = 181

% Expired Patents = 2.2

CIPO Patents = 4

EPO Patents = 57

Forward Citations = 3,696

Loading Chart...

Loading Chart...

41 inventors (with patents filed for the assignee):

Peng Li (135 out of 151 patents)

Lawrence P Wennogle (102 out of 102 patents)

Robert E Davis (72 out of 145 patents)

4. Sharon Mates (39 out of 40 patents)

5. Qiang Zhang (29 out of 31 patents)

6. Kimberly Vanover (27 out of 27 patents)

7. Hailin Zheng (24 out of 24 patents)

8. Jun Zhao (24 out of 26 patents)

9. Wei Yao (22 out of 24 patents)

10. John Charles Tomesch (21 out of 24 patents)

11. Gretchen Snyder (20 out of 22 patents)

12. Allen Fienberg (12 out of 14 patents)

13. Andrew S Thompson (10 out of 75 patents)

14. Joseph Hendrick (10 out of 10 patents)

15. Robert Davis (10 out of 10 patents)

Core Competencies:

Lumateperone

Pharmaceutical Compositions

Central Nervous System

Gamma-Carbolines

Transmucosal Methods

Organic Compounds

Acute Depression

Anxiety Treatments

Heterocycle Synthesis

Amorphous Solid Dispersions

Cardiotoxicity Inhibition

PDE1 Inhibitors

181 patents: Sort by Forward Citations

1. 12685731 - Organic compounds (2026-07-21),

2. 12636287 - Organic compounds (2026-05-26),

3. 12624037 - Method of treating agitation, aggressive behavior, and impulse control disorder (2026-05-12),

4. 12624036 - Method of treating post-traumatic stress disorder (2026-05-12),

5. 12605384 - Uses (2026-04-21),

6. 12599603 - Methods of treatment (2026-04-14),

7. 12565499 - Compounds and methods (2026-03-03),

8. 12533355 - Methods of treatment comprising administering lumateperone mono-tosylate capsules (2026-01-27),

9. 12496300 - Methods of treating acute depression and anxiety (2025-12-16),

10. 12478623 - Methods of treating central nervous system disorders comprising administering lumateperone and a nitric oxide donor (2025-11-25),

11. 12472178 - Amorphous solid dispersions (2025-11-18),

12. 12465570 - Methods (2025-11-11),

13. 12440489 - Organic compounds (2025-10-14),

14. 12435093 - Free base crystals (2025-10-07),

15. 12414948 - Methods (2025-09-16),

Intra-Cellular Therapies, Inc. is a biopharmaceutical company that focuses on the discovery and development of innovative medicines to treat central nervous system (CNS) disorders. The company's mission is to address unmet medical needs and improve the lives of patients suffering from mental health disorders. Through their proprietary technology, they develop novel therapeutics that target specific pathways within the CNS. Intra-Cellular Therapies is committed to advancing scientific research and bringing transformative treatments to people in need.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

181 Patents

#1 in Bedminster, NJ

#101 in New Jersey

#2,235 in US

#4,595 in the World

Bedminster, NJ, United States of America

Intra-Cellular Therapies, Inc.

Forward Citations = 3,696

41 inventors:

Peng Li (135 out of 151 patents)

Lawrence P Wennogle (102 out of 102 patents)

Robert E Davis (72 out of 145 patents)

4. Sharon Mates (39 out of 40 patents)

5. Qiang Zhang (29 out of 31 patents)

Please report any incorrect information to [email protected]

Loading…